Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Wound Care Articles

Taiwanese Study Shows New Technology Nearly Three Times Better at Healing Diabetic Foot Ulcers
New Wound Treatment for Non-healing Foot Ulcers
Dermagraft
Wound Care Company Signs Sponsorship Agreement With ADA
No More Slow-to-Heal Wounds
Drug That Binds Iron Could Be a Godsend For Stubborn Limb Wounds
Saving Limbs by Healing Chronic Diabetic Foot and Leg Wounds
Foot Care for Diabetics
Hyperbaric Oxygen Therapy Used to Treat Diabetic Ulcers at New Massachusetts Center
Ask Your Doctor: Is Honey Wound Salve Right For You?
Diabetes Health Reference Charts
Mail Order Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Skin and Foot Care Reference Guide (PDF)
See All Charts…
Wound Care Archives
Browse the Wound Care Archives
Subscribe to the Complications & Care RSS Feed
Print | Email | Share | Comments (0)

FDA Approves Apligraf for Treatment of Diabetic Foot Ulcers—Live Skin Used to Heal Foot Wounds

Aug 1, 2000

Only a month and 12 days after receiving recommendation for approval from a FDA advisory board, Apligraf was formally given approval for the treatment of diabetic foot ulcers of greater than a three-week duration.

Apligraf, supplied as a bi-layered living skin substitute, received FDA marketing clearance in 1998 for use in the treatment of venous leg ulcers. In clinical trials, Apligraf was shown to heal more diabetic foot ulcers faster than conventional therapy alone. By 12 weeks of treatment, 56 percent of diabetic foot ulcers treated with Apligraf were 100 percent closed, compared to 39 percent treated with conventional therapy alone.

"Apligraf will change the way we manage our patients with diabetic foot ulcers," says Lawrence B. Harkless, DPM, professor of podiatric medicine and surgery at the University of Texas Health Sciences Center in San Antonio, Texas. "The burden of diabetic foot ulcers to individuals and society demonstrates the need for new and better products to treat these devastating wounds."

Between 600,000 to 800,000 people in the United States currently suffer from diabetic foot ulcers.

For more information, call 781-575-0775.

Categories: Diabetes, Diabetes, Foot Care, Government & Policy, Wound Care

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Aug 1, 2000

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.